Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Investors dive into bonds as global AI tech selloff continues

November 6, 2026

‘Kate & Allie’ star Susan Saint James cause of death revealed

November 6, 2026

Crossing guard hit in Richmond Hill crash following string of pedestrian collisions

November 6, 2026

This see-through camera lets photographers maintain eye contact with their subjects

November 6, 2026

U of T’s dentistry dean to step down following antisemitic images in course material

November 6, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » InkSpace Imaging receives FDA Clearance for a 24-channel Small Body Array Compatible with Siemens Healthineers 3T Systems
Press Release

InkSpace Imaging receives FDA Clearance for a 24-channel Small Body Array Compatible with Siemens Healthineers 3T Systems

By News RoomJanuary 11, 20243 Mins Read
InkSpace Imaging receives FDA Clearance for a 24-channel Small Body Array Compatible with Siemens Healthineers 3T Systems
Share
Facebook Twitter LinkedIn Pinterest Email

PLEASANTON, Calif., Jan. 11, 2024 (GLOBE NEWSWIRE) — InkSpace Imaging, a leader in innovative diagnostic medical device technology, is proud to announce it received FDA clearance for its next-generation Small Body Array for the Siemens Healthineers Magnetom Skyra and Vida series 3T MRI scanners. This new medical device is part of their industry-leading suite of MR coils designed to revolutionize the patient experience while enhancing efficiency in MRI scans and clinical diagnosis.

The technologically advanced Small Body Array is huggable, lightweight, and flexible. It wraps around patients like a blanket, ensuring unparalleled image quality. The body contouring design optimizes the signal-to-noise ratio, which is crucial for detecting subtle abnormalities often missed by standard rigid, conventional coils. This leap in image quality means quicker and more accurate diagnoses, especially in complex cases.

This design marks a dramatic shift from conventional coils, as InkSpace Imaging’s coils are up to 80 percent lighter and provide a 10-40% faster throughput. The design of the Small Body Array is especially noteworthy for its flexibility which allows it to conform to a wide,e range of patient anatomies and sizes, significantly reducing scan times and minimizing the duration patients need to remain still. This adaptability ensures all patients receive optimal imaging experiences, enhanced patient comfort, and significantly benefits technologists by streamlining the imaging process due to its high coil element density.

Dr. Peter Fischer, CEO of InkSpace Imaging, stated: “The FDA clearance of InkSpace Imaging’s Small Body Array marks a pivotal moment in MRI technology advancement. Our suite of MR coils is a game-changer, offering total freedom in coil positioning and handling. What’s truly impressive is how our thin flexible coil contours to each patient’s body, offering comfort while enhancing image quality. It’s a win-win for patients and healthcare providers alike.”

The FDA clearance of InkSpace Imaging’s Small Body Array is a testament to the company’s commitment to innovation and improving patient care. This breakthrough technology again sets a new standard in MRI imaging.

About InkSpace Imaging

InkSpace Imaging is an award-winning medical device manufacturer specializing in lightweight and flexible MRI receive coils for Diagnostic Imaging and Multi-modality systems. Their body arrays allow radiologists to customize MRI experiences for individual patients that improve treatment outcomes and enhance patient-centered care. The breakthroughs led by InkSpace Imaging are setting new standards in radiology, making them a leader in the field.

Media Contact
Howard Peters
Vice President, Sales and Marketing
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/230b49e4-18d5-4f90-ac8b-5d2a90d5cd52 

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

vineyard vines Returns as Official Style of the Head Of The Charles® Regatta

Bigger & Better Than Ever: Laxmi & Chef Kunal Kapur Return With ‘Diwali Delights’ Season 2

2026 Chery International User Summit to Kick Off: LUXEED Set for Global Brand Launch

Going Asset Management Wins Capital’s Excellence Fund Award, Harnessing Technology to Enhance the Long-Term Value of Assets

Alation Honors 2026 AI Radicals Award Winners at revAlation

Supported Employment: Helping Individuals Build Meaningful Careers

“The Carbon Pursuit of Happiness” Premieres October 10: A New Chapter for In-Depth Dialogue on Health and Humanity

Evolution Metals & Technologies Corp. Raises Fiscal 2026 Revenue Guidance 62% at Midpoint to 11 Million and Reaffirms 460 Million Fiscal 2027 Outlook

Ufunded Launches “Spotlight” Series, Documenting the Minds Shaping Modern Trading

Editors Picks

‘Kate & Allie’ star Susan Saint James cause of death revealed

November 6, 2026

Crossing guard hit in Richmond Hill crash following string of pedestrian collisions

November 6, 2026

This see-through camera lets photographers maintain eye contact with their subjects

November 6, 2026

U of T’s dentistry dean to step down following antisemitic images in course material

November 6, 2026

Latest News

TikTok’s For You page needs to change, says the EU

November 6, 2026

Cineplex posts record revenue as Spider-Man, Odyssey drove moviegoers

November 6, 2026

Budget 2026 proposes 1st deposit insurance limit increase in 2 decades

November 6, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version